News

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.

Key leadership appointments support integration of the Group and expansion in the US market.

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

A protein involved in cognition and storing long-term memories looks and acts like a protein from viruses.

The viral properties and history of Arc, a protein important for memory and cognition, have been unearthed in a new study.

A biochemical study has produced reliable figures estimating protein number in simple cells for the first time.

Scientists have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.

When you see brown spots on otherwise healthy green leaves, you may be witnessing a plant’s immune response as it tries to keep a bacterial infection from spreading. Some plants are more resistant to such infections than others, and plant biologists want to understand why. Scientists studying a plant protein called SOBER1 recently discovered one mechanism by which, counter-intuitively, plants seem to render themselves less resistant to infection.

A new study has highlighted molecules that may be key to the Zika virus's ability to evade the body's safeguards and cause brain damage.

Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.